Avidity Biosciences, Inc.
KRAS nucleic acids and uses thereof

Abstract:

Disclosed herein are molecules and pharmaceutical compositions that mediate RNA interference against KRAS. Also described herein include methods for treating a disease or disorder that comprises a molecule or a pharmaceutical composition that mediate RNA interference against KRAS.